Gilead Sciences Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2025
Total Assets: $59.02B
Liabilities Breakdown FY2025
Total Liabilities: $36.32B
Asset Breakdown
Total Assets: $59.02B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.56B | 12.8% |
| Accounts Receivable | $4.91B | 8.3% |
| Inventory | $1.77B | 3.0% |
| Property, Plant & Equipment | $5.61B | 9.5% |
| Goodwill | $8.31B | 14.1% |
| Intangible Assets | $16.98B | 28.8% |
| Other Assets | $13.87B | 23.5% |
Liabilities Breakdown
Total Liabilities: $36.32B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $715.0M | 2.0% |
| Long-Term Debt | $22.13B | 60.9% |
| Other Liabilities | $13.48B | 37.1% |